Technology

A European Biotech Stock Basket For 2015 – An Update | Seeking …

SummaryAs an update from my previous article, I am reviewing some European biotech picks and introducing new favorites.
Owing to strong fundamentals and an increasing number of significant deals in the sector, a technologically diversified, European biotech portfolio makes more sense now than ever.
The main investment thesis remains that leading small-cap European biotechs are reaching maturity and present a great value […]

Janet Yellen comments on biotech valuations in 2014 – Business …

Janet Yellen is facing Congress on Wednesday for her semi-annual testimony.And one year ago today, Yellen’s monetary policy report warned about stock market valuations, particularly in social media and biotech stocks. It was an awful call. Yellen’s testimony last year said:”Some broad equity price indexes have increased to all-time highs in nominal terms since the end of 2013. However, valuation measures for the overall market in […]

Short Sellers Shy Away From Biotech Stocks – Benzinga

Related ALXNUS Stock Futures Drop Ahead Of Economic DataStrensiq Receives Marketing Approval in Japan for Treatment of Patients with HypophosphatasiaBy and large, the number of shares short in the leading biotech and emerging pharmaceutical stocks shrank between the June 15 and June 30 settlement dates.The trend was particularly noticeable in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Gilead Sciences, Inc. (NASDAQ: […]

Biotech Stocks To Keep Your Eye On | Gilead Sciences (GILD) | BG …

Markets are rebounding today after a horrible beginning to the week. Looking in the biotech sector, I’m seeing a sea of green with very few blemishes. I’ve also been able to dig out a few great opportunities in the sector. Here they are…Gilead Sciences Is Likely To See Long Run GainsGilead Sciences, Inc. (NASDAQ: GILD)I’ve talked about Gilead Sciences quite […]

Biotech stock bubble set for massive implosion: Stocks rose 88 …

(NaturalNews) If you’re trying to understand today’s stock market and are having some degree of difficulty, you’re not alone.The markets are confusing enough sometimes for experts, so they can be particularly baffling for laypersons. Still, a few economic basics ought to be pretty simple to understand, right?Wrong – apparently.About a year ago, as documented by the Zero Hedge website, Federal […]

Greece Saved the Biotech Bull Market! – Daily Reckoning

Biotechs rise on Greece ‘No’ Vote!Amazing news, right? I mean, who would think the news out of Greece would push biotech stocks higher?But apparently it did. The Greek people let the world know they ain’t interested in more austerity (not that they really had any). Meanwhile, biotechs were the strongest group of stocks on the market to kick off the […]

Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead …

One of the most popular and well-known names in the biotech world is definitely Biogen (BIIB-Analyst Report). This large cap stock has been a staple of investor portfolios in the biotechnology space for some time, while it is also one of the behemoths of the sector, closing in on $100 billion in market cap.BIIB might be due for a breather […]

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal …

The Celgene Corporation (CELG – Analyst Report) – Juno Therapeutics’ (JUNO – Analyst Report) immunotherapy deal worth at least a billion dollars was the main story in the biotech sector this week. While concerns are being raised about the high price tag, the deal just goes to show the growing interest in the field of immunotherapy. Meanwhile, quite a few […]

5 Biotech Stocks On Deck With The FDA – Benzinga

Some traders like to gamble on big news events that could have a dramatic effect on a particular stock. For example, the release of a company’s earnings report could cause an underlying stock to jump to new highs or drop to significant lows. While this may not interest all investors, it does prove to be a point of intrigue for […]

Biotech Stock News (EPZM) (VICL) (ALPMF) (CBLI) | CNA Finance

Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]